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Elk3/Net/Sap2 (here referred to as Elk3) is an Ets ternary complex transcriptional repressor known for its
involvement in angiogenesis during embryonic development. Although Elk3 is expressed in various
tissues, additional roles for the protein outside of vasculature development have yet to be reported.
Here, we characterize the early spatiotemporal expression pattern of Elk3 in the avian embryo using
whole mount in situ hybridization and quantitative RT-PCR and examine the effects of its loss of
function on neural crest development. At early stages, Elk3 is expressed in the head folds, head
mesenchyme, intersomitic vessels, and migratory cranial neural crest (NC) cells. Loss of the Elk3 protein
results in the retention of Pax7þ precursors in the dorsal neural tube that fail to upregulate neural
crest speciﬁer genes, FoxD3, Sox10 and Snail2, resulting in embryos with severe migration defects.
The results putatively place Elk3 downstream of neural plate border genes, but upstream of neural crest
speciﬁer genes in the neural crest gene regulatory network (NC-GRN), suggesting that it is critical for
the progression from progenitor to deﬁnitive neural crest cell.
& 2012 Elsevier Inc. All rights reserved.Introduction
Neural crest (NC) cells are a transitory and vertebrate-speciﬁc
cell type that are induced at the border of the neural plate and the
non-neural ectoderm, and subsequently come to reside within the
neural folds during neurulation. After neural tube closure, these
cells delaminate from the neuroepithelium and migrate to distant
locations in the embryo where they differentiate into multiple
derivatives, including craniofacial cartilage and bone, neurons and
glia of the peripheral nervous system, and melanocytes (Rogers
et al., 2012). These cells are unique and interesting because they
resemble stem cells in their ability to form multiple derivatives,
as well as metastatic cancer cells in their ability to migrate and
invade different tissues. Abnormal NC development can result in
defective embryogenesis leading to birth defects.
A proposed neural crest gene regulatory network (NC-GRN)
helps to explain some of the molecular interactions that are
involved in neural crest cell speciﬁcation, and their subsequent
epithelial to mesenchymal transition (EMT) that leads to the
formation of the migratory population (Sauka-Spengler and
Bronner-Fraser, 2008). An important goal in the neural crest ﬁeld
is to identify additional factors that are involved in the NC-GRN,
and to test their possible developmental roles. To aid in this goal,ll rights reserved.
rs).we previously conducted screens for genes that are upregulated
during the process of neural crest formation (Adams et al., 2008;
Gammill and Bronner-Fraser, 2002). Several transcription factors
were identiﬁed that had not previously been known to function in
the neural crest.
One of the genes upregulated as a consequence of neural crest
induction is Elk3/Net/Sap2 (referred to hereafter as Elk3),
a ternary complex factor that belongs to the Ets family of
transcription factors. Elk3 is a transcriptional repressor that has
been linked to cancer metastasis (Li et al., 2008; Sloan et al.,
2009), wound healing, and vasculogenesis in cell lines and in mice
(Ayadi et al., 2001b; Nozaki et al., 1996; Zheng et al., 2003).
However, little is known about its role in normal embryonic
development, although in vitro studies have suggested a role in
cell migration (Buchwalter et al., 2005). Elk3 is expressed in the
developing vasculature, the cranial mesenchyme and the limb
buds of mouse embryos (Ayadi et al., 2001b). In addition, in vivo
studies of the function of Elk3 during tumorigenesis in mice
showed that individuals lacking Elk3 protein had smaller tumors
due to their inability to become vascularized and oxygenated
(Zheng et al., 2003).
Although well studied in vitro as a ternary complex factor,
little is known about the function of Elk3 during early embryonic
development. Here, we describe the spatiotemporal expression
pattern and function of Elk3 during avian embryogenesis.
In addition to its previously known distribution in the vascula-
ture, we report that Elk3 is expressed in the neural folds and
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Elk3 protein prevents proper neural crest speciﬁcation, inhibits
migration and results in the retention of precursor cells in the
dorsal neural tube. Thus, in addition to its role in the vascular
system, Elk3 also plays a critical role in neural crest development.Materials and methods
Embryos
Fertilized chicken eggs were obtained from local commercial
sources (McIntyre Farms, San Diego, CA) and incubated at 37 1C to
the desired stages according to the criteria of Hamburger and
Hamilton (HH). For whole mount in situ hybridization (WISH),
embryos were ﬁxed for one hour to overnight in 4% paraformal-
dehyde (PFA) at room temperature or 4 1C, respectively, washed
in PTW (PBS containing 0.1% Tween) and dehydrated in MeOH at
room temperature before being stored at 20 1C in 100% MeOH.RNA preparation and quantitative PCR
RNA was prepared from embryos (n¼10) using the RNAqueous-
Micro isolation kit (Ambion) following the manufacturer’s instruc-
tions. The obtained RNA was treated with DNaseI ampliﬁcation
grade (Invitrogen) and then reversed-transcribed to cDNA with
SuperScript II (Invitrogen) using random hexamers. QPCR was
performed using the 96-well plate ABI 7000 QPCR machine with
Sybrgreen Itaq Supermix with ROX (Bio-Rad), 150–450 nM of each
primer, and 200–500 ng of cDNA in a 25 ml reaction volume.
During the exponential phase of the QPCR reaction, a threshold
cycle (CT) and baseline was set according to the protocols of
Applied Biosystems. The results for different samples were then
analyzed using the Livak/DDCt method. There were three repli-
cates for every sample and GAPDH was used as a control.Electroporation of antisense morpholinos and DNA vectors
Two translation blocking antisense morpholinos to Elk3 (E3MO)
were designed: E3MO1: 50-TGTTCAGAGGGAGCTGGGTAAAACC-30,
E3MO2: 50-TGATTGCACTCTCCATACCCAGAGC-30 and one control
morpholino (ContMO) was used: 50-CCTCTTACCTCAGTTACAATT-
TATA-30. Injections of the ﬂuorescein-tagged morpholino (1–3 mM
plus 0.5–1.5 mg/ml of PCI carrier plasmid DNA) (Voiculescu et al.,
2008) were performed by air pressure using a glass micropipette
targeted to the presumptive neural crest region at HH stages 4–5.
Rescue experiments were performed in the same manner as E3MO
electroporations except that the PCI-Elk3-RFP plasmid was used
(.75 mg/ml) instead of the PCI carrier plasmid. Stage 4–5 electro-
porations were conducted on whole chick embryo explants placed
ventral side up on ﬁlter paper rings. The Elk3 morpholinos and
vectors were injected on the right side of the embryo, and the
controls were injected on the left side when co-injected, and
platinum electrodes were placed vertically across the chick
embryos and electroporated with ﬁve pulses of 6.3 V in 50 ms at
100 ms intervals. The embryos were cultured in 1.0 ml of albumen
in petri dishes until they reached the desired stages. The embryos
were then removed and ﬁxed for one hour to overnight in 4% PFA
at room temperature or 4 1C, respectively. The embryos were
placed in PTW, viewed and photographed as whole mounts using
a ﬂuorescence stereomicroscope to show the electroporation
efﬁciency.Whole mount in situ hybridization (WISH)
Chick WISH was performed as previously described (Acloque
et al., 2008) with the following modiﬁcations: embryos were not
treated with proteinase K, triethanolamine, or acetic anhydride,
on day one, and the day two washes were shortened, no CHAPS
was used and MABT was used instead of KTBT. The linearized
plasmid DNA templates that were used for digoxigenin- and
ﬂuorescein-labeled RNA probes were Elk3, FoxD3, Sox10, Snail2
and Sox2. The embryos were imaged in whole mount and were
then transverse sectioned at 14–25 mm in a Microm HM 550
cryostat.
Immunohistochemistry
Immunohistochemistry for Pax7 (Developmental Studies
Hybridoma Bank (DSHB, Pax7), HNK1 (DSHB, 3H5), Snail2 (DSHB,
62.1E6), Sox2 (R&D Systems, AF-2018), Pax6 (Covance, PRB-2184),
Caspase (R&D Systems, AF835) and PH3 (Upstate/Millipore,
06–570) was performed as follows. Embryos were ﬁxed in 4%
paraformaldehyde in phosphate buffer for twenty minutes at
room temperature. All washes were performed in TBSTþCa2þþ
with.5% triton x-100. Blocking was performed with 10% donkey
serum in the same buffer. The primary antibodies (1:10 for all
hybridoma antibodies and 1:1000 for all others) were incubated
in the TBST buffer from overnight to two days at 41 and secondary
antibodies (1:500 to 1:1000) were applied in the same buffer for
either three hours at room temperature or overnight at 41.
Cell death and proliferation
Embryos were immunostained with the proliferation marker
phosphorylated histone H3 (rabbit anti-PH3 IgG, 1:1000) or the
apoptosis marker, caspase (rabbit anti-caspase IgG, 1:1000), and
then detected using the secondary Alexa Fluor goat anti-rabbit
350 (1:1000).Results
Sequence of chick Elk3 protein
The chick Elk3 protein is highly conserved with human, mouse
and zebraﬁsh (Fig. 1A), exhibiting an overall amino acid sequence
similarity of 86%–88% with mouse and human, respectively, 60%
similarity with zebraﬁsh and approximately 98% conservation in
the functional domains between organisms. The chick Elk3
protein contains an Ets binding domain (amino acid (a.a.) residues
1–89), a serum response factor interaction domain (a.a. 141–162),
two repressor domains (a.a. 166–176, 283–293), a mitogen
activated protein (MAP) kinase docking site (a.a. 299–302) and a
MAP kinase transcriptional activation site (a.a. 335–388).
Expression of Elk3 in the chick embryo
Using in situ hybridization to visualize the spatiotemporal
expression pattern of transcripts, the Elk3 expression pattern
appears very dynamic throughout the early stages of chick
development. Elk3 is expressed in the anterior primitive streak
by Hamburger–Hamilton (HH) stage 4 (Fig. 1B) and in the
developing head folds and head mesenchyme at HH8 (Fig. 1C,
and C0). Elk3 is expressed at low levels in the early neural folds
(Fig. 1C0), and transcript levels appear to decrease around the time
of neural tube closure. At HH9, Elk3 remains in the developing
head mesenchyme (Fig. 1D), which will eventually contribute
to portions of the craniofacial bone, vasculature and muscle
Fig. 1. Expression of Elk3 during avian development. (A) Schematic diagram of the Elk3 protein with the six functional domains (identiﬁed by color) and the amino acid
sequence. (B–F) Whole mount in situ hybridization (WISH) of Elk3 at stages HH4 (B), HH8-(C), HH9 (D), HH11 (D), and HH20 (F). Elk3 is expressed in the developing head
mesenchyme, neural folds and migratory neural crest cells, intersomitic vessels and the developing limb buds. (E0) Section of HH11 embryo from (E). WISH of Elk3
expression (top panel), immunohistochemistry of HNK1 (middle panel) and Pax7 (bottom panel). Overlays (right side) showing that Elk3 expression overlaps with
migratory cells. (G) Quantitative PCR showing the expression of the Elk3 transcript compared with HH4 embryos and normalized with GAPDH expression. The Livak/DDCt
method was used for the quantitative analysis. Scale bars: 200 mm (B–F), 100 mm (C0 , E0).
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subpopulation of migrating cranial NC cells at HH10- 11, as well
as in the R4 migratory stream and the cranial mesenchyme
(Fig. 1E, and E0). Elk3 transcripts partially overlap with the
migratory neural crest cell marker, HNK1 (Fig. 1E0, green), and
with Pax7 in the migratory crest (Fig. 1E0, red), but are below the
level of detection by in situ hybridization in the dorsal neural tube
(Fig. 1E0). By HH stage 20, Elk3 is expressed in the developing limb
buds, the branchial arches, and the intersomitic blood vessels
(Fig. 1F) similar to the patterns described in mouse embryos
(Ayadi et al., 2001a).
To determine the quantitative expression levels of Elk3, we
performed quantitative PCR (QPCR) on 10 whole embryos from
stages HH4–HH11. When normalized to GAPDH expression and
compared to the Elk3 expression levels at HH4 using the
LivakDDCt method, Elk3 appears to be expressed at low levels
through stages HH4-6, and the expression increases at HH7 just
prior to the onset of neural crest speciﬁers like FoxD3 and Snail2.
The expression peaks between stages HH8-11, as neural crest
cells commence migration, and levels remain high as develop-
ment proceeds (Fig. 1G).
Elk3 is required for cranial NC speciﬁcation
Because Elk3 is expressed in the developing head folds begin-
ning at HH7, we blocked the expression of the Elk3 protein duringgastrulation at HH4 by electroporating one of two translation
blocking morpholinos, referred to throughout as ‘‘E3MO’’, prior to
the onset of Elk3 expression in the neural folds. To examine the
effects of Elk3 knockdown on cranial NC speciﬁcation, we per-
formed whole mount in situ hybridization (WISH) for the neural
crest speciﬁer genes, FoxD3 and Sox10 (Fig. 2A–E). Loss of the Elk3
protein greatly reduced the number of FoxD3-expressing cells on
the injected side of the embryo at HH8 (Fig. 2A, arrow, N¼11/14),
consistent with a requirement for Elk3 in cranial NC speciﬁcation.
In addition, the expression of Sox10 was greatly reduced on the
Elk3-morphant side of the embryo at the same stage (Fig. 2C,
arrow, N¼9/10). In transverse section, only cells lacking E3MO
are seen to express Sox10 (Fig. 2E). Overexpression of the pCI-RFP-
Elk3 DNA construct in concert with E3MO at HH4 was sufﬁcient
to rescue the expression of both FoxD3 and Sox10 at HH8 (Fig. 2B
and D, N¼6/8 and 10/14, respectively), demonstrating the speci-
ﬁcity of the effect. In addition, we examined Snail2 protein
expression which, similar to FoxD3 and Sox10, was reduced at
HH9 after Elk3 knockdown (Fig. 2F and F0, arrow, N¼15/16).
The effects of Elk3-knockdown on the neural crest speciﬁer
genes, FoxD3, Sox10, and Snail2 prompted us to examine the
requirement of Elk3 for the expression of the neural plate border
gene, Pax7, which is required for neural crest formation during
gastrulation and lies upstream of neural crest speciﬁer genes in
the neural crest gene regulatory network (Basch et al., 2006;
Betancur et al., 2010). During normal development, Pax7 is
Fig. 2. Elk3 is required for cranial NC speciﬁcation. (A–E) Whole mount in situ hybridization of FoxD3 (A) and (B) and Sox10 (C–E) in embryos electroporated at HH4 with
either the E3MO alone ((A), (C), 2.5–3 mM, arrows show loss of expression) or the E3MO with Elk3-RFP DNA ((B), (D), 3 mM and 3 mg/ml). (E) Section of embryo ﬁxed at
HH9 showing WISH for Sox10 expression (top panel) which is downregulated in the cells with E3MO (middle panel) and the overlay (bottom panel). (F), (G)
Immunohistochemistry of embryos electroporated at HH4 with ContMO on left and E3MO on right showing Snail2 (down-regulation on right side compared with control
side) and Pax7 protein expression. Dashed lines are sections of these embryos shown in (F0) and (G0). (H), (I) Sections of HH9 embryo electroporated with RFP on the left
side and Elk3 over-expression construct on the right side, whole mount immunohistochemistry for Snail2 (green, left panel) and Pax7 (green, right panel) was performed.
Sections of these embryos are shown in (H0) and (I0) and overlay is below showing RFP from DNA constructs in red. Scale bars: 200 mm ((A)–(D), (F)–(I)), 100 mm ((E),
(F0)–(I0)).
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neural folds and is also expressed by migratory neural crest cells.
Therefore, Pax7 represents a good marker for assessing whether
Elk3 is required for maintenance of the neural crest precursor
pool. Surprisingly, we noted that the loss of Elk3 resulted in a
maintenance or increase of Pax7 protein in dorsal neural tube
cells (Fig. 2G and G0, asterisk, N¼13/14) concomitant with the
loss of FoxD3 and Sox10. Sections of an HH8-9 embryo immunos-
tained for Pax7 expression show that Pax7 levels are unaffected in
the presumptive midbrain at this stage (Fig. 2G0, asterisk), and
may be increased in more posterior and ‘‘younger’’ dorsal neural
tube cells (data not shown). This phenotype is consistent with the
possibility that Elk3 may be required for the transition of NC
precursors to NC cells, and that the loss of Elk3 maintains newly
induced precursors in a ‘‘stem-like’’ state prior to the onset of
deﬁnitive neural crest markers.
Since the loss of Elk3 led to a decrease in NC cell speciﬁer
genes and a maintenance or upregulation of Pax7, we examined
whether the addition of exogenous Elk3 had an effect on neural
crest speciﬁcation. To this end, we electroporated an overexpres-
sion construct (pCI-Elk3-RFP, here referred to as ‘‘Elk3’’) at HH4.
The results suggest that Elk3 overexpression reduces the numbers
of migratory Snail2þ neural crest cells while causing a minor
upregulation of Snail in the premigratory neural crest (Fig. 2H and
H0, N¼6/8). Pax7 appeared to be slightly decreased in a subset of
the embryos (Fig. 2I and I0, N¼4/7) on the Elk3-injected side. The
results suggest that over-expression of Elk3 can effect neural crest
development, though not exactly opposite to that of its knock-
down. These data are consistent with the possibility that main-
tenance of appropriate levels of this transcription factor in the
neural crest is critical.
To determine when Elk3 activity is required during neural
crest speciﬁcation, we electroporated the E3MO from stages
HH4–HH8. Elk3 knockdown between stages HH4 and HH6
yielded similar results to those described in previous experi-
ments; Sox10 expression and neural crest migration were reduced
at both stages (Fig. 3A and B, E and F, N¼16/20). When the E3MO
was electroporated at HH5, Pax7 and HNK1 expression were lost
in migratory neural crest cells similar to the effects of electro-
porations at HH4 (Fig. 3E and E0 compared to Fig. 2G and G0, N¼4/
5). Electroporations performed at HH6 also affected Pax7 and
HNK1 expression in migratory cells, but to a lesser extent (Fig. 3F
and F0, N¼5/6). Thereafter, the effects were less penetrant with
embryos appearing morphologically normal at stages 7/8 (Fig. 3C
and D, G, N¼8/8), but somewhat delayed neural crest migration
that was only detectable after sectioning (Fig. 3G0, arrow). To
determine if the reduction of FoxD3 and Sox10 expression was due
to a decrease in proliferation or an increase
in cell death, we performed immunohistochemistry using a
proliferation marker, phosphorylated histone H3 (PH3), and a
marker of apoptosis, caspase, after knockdown of Elk3 using the
E3MO. The results show that loss of the Elk3 protein had little
effect on proliferation as evidenced by similar levels of PH3 on the
injected and uninjected internal control side in both the whole
mount and section (Fig. S1A, S1C-D, N¼9/11). This suggests that
the loss of speciﬁer genes is not due to a lack of proliferation.
However, knocking down Elk3 at HH4 did cause a slight increase
in cell death mainly localized to the ventral neural tissue
(Fig. S1B, S1E, N¼12/15). Curiously, the ventral neural tube lacks
Elk3 expression suggesting that this affect may be non-cell
autonomous. In addition, we examined the effects of Elk3-RFP
overexpression to determine if it is sufﬁcient to induce cell
proliferation or if excess Elk3 affects cell death. Overexpression
of Elk3 had little effect on PH3 (Fig. S1F, S1H, N¼6/6) or caspase
(Fig. S1G, S1I, N¼4/4) expression when compared to the control
(RFP, left side).Elk3 is not required for neural development
The neural plate border region can give rise to either neural
crest or dorsal neural tube cells, which become part of the CNS
(Krispin et al., 2010). Therefore, to verify that the loss of the
neural crest speciﬁer expression that was observed after Elk3
knockdown was not due to the inhibition of neural development,
we electroporated the E3MO into HH4 embryos and performed
WISH for the neural gene, Sox2, and performed immunohisto-
chemistry for Sox2 and Pax6 proteins, both of which mark neural
cells. The loss of Elk3 did not affect the expression of Sox2 (Fig. 4A,
N¼5/6) when compared to the ContMO (Fig. 4B). In addition,
immunohistochemistry for Sox2 (neural progenitors) and Pax6
(neural and ectodermal tissues) proteins, showed that there is no
decrease in the expression of either Sox2 (Fig. 4C and C0, N¼12/13)
or Pax6 (Fig. 4D and D0, N¼10/10) in the neural tube, and the
ectoderm marked by Pax6 is unaffected in the Elk3-morphant cells
(Fig. 4D0). Additional experiments were performed to determine if
Elk3 overexpression affected neural development. Embryos
injected with RFP (left side) and Elk3 (right side) had little change
in Sox2 protein expression (Fig. 4E and E0, N¼4/4). These data
support a role for Elk3 speciﬁcally in the development of cranial NC
cells independent of non-NC ectodermal derivatives.
Elk3 knockdown reduces cranial NC migratory streams and
anterior cranial structures
Although Elk3 plays a clear role in cranial NC cell speciﬁcation,
the Elk3 transcript is also expressed in migratory cranial NC cells.
To examine if Elk3 is required for EMT or migration, we electro-
porated E3MO into HH4 embryos and performed WISH for Sox10
(Fig. 5A and B) and Snail2 (Fig. 5C and D) expression at migratory
stages. The results show that loss of Elk3 has a dose dependent
effect on both Sox10 (N¼17/22) and Snail2 (N¼9/12) expression
in the migratory crest. At 1.5 mM, the E3MO reduces the migra-
tory ﬁeld marked by both Sox10 and Snail2 in stage HH9–HH10
embryos (Fig. 5A, and C). At 3 mM, the cranial NCs expressing
Sox10 and Snail2 appeared to be even more reduced (Fig. 5B and
D). We performed immunohistochemistry with the HNK1 anti-
body, which labels migrating neural crest cells, and observed a
profound decrease in HNK1 expression as well as the distance
traveled by these cells on the E3MO-injected side compared to the
control MO injected side (Fig. 5E, compare right side with left
side, N¼11/11). Despite the reduction in Sox10, Snail2 and HNK1-
positive migratory cells, prominent Pax7-expressing cells
remained in the dorsal neural tube at HH9 (Fig. 5F, N¼9/9). In
fact, the only Pax7-positive migratory cells are E3MO negative
and hence are able to migrate laterally at HH10 (Fig. 5G) whereas
the Pax7þ/E3MOþ cells remain in the dorsal neural tube. These
data support a role for Elk3 in the transition from Pax7-positive
progenitor cells at the onset of NC cell speciﬁcation to FoxD3/
Snail2/Sox10-positive cells that form bona ﬁde migratory neural
crest cells.
To determine if the effects of Elk3 knockdown recovered over
time, E3MO-electroporated embryos were allowed to survive
until 2–3 days post-electroporation (HH16-17). In all cases
(n¼7), the embryos exhibited severe anterioposterior head axis
shortening (Fig. S2, asterisks) and craniofacial defects character-
ized by the loss of the most anterior structures, like the olfactory
placode, a posterior to anterior shift of the eyes, and more
dispersed and anteriorly-localized Sox10þ neural crest cells. In
addition, the embryos exhibited abnormal branchial arch devel-
opment, lack of trigeminal ganglion development and a failure to
close the frontonasal process (Fig. S2, arrow). All embryos also
had posterior blood vessel edema and heart developmental
defects when compared to uninjected controls (data not shown).
Fig. 3. Loss of Elk3 affects cranial NC development in a stage-dependent fashion. (A–D) Whole mount in situ hybridization of Sox10 in embryos electroporated at stages
HH5–HH8 with the E3MO on the right side (asterisks) and ContMO on the left side. E3MO affects neural crest development at all stages, but the severity declines with time
and is not obvious by whole mount when electroporated at stage 8 (D). (E–G) Whole mount immunohistochemistry with antibodies to Pax7 (red) and HNK1 (blue) in
embryos electroporated at stages HH5–HH8 with the E3MO on the right side and ContMO on the left side (Fitc, green). (E) Similar effects are seen when E3MO is
electroporated at stages HH5-6 as at earlier stages (see Figs. 2, 5). (F and G) At HH7-8, the effects are less dramatic, but a delay in neural crest migration is still evident. (E0–
G0) Cryosections of embryos from (E) to (G) showing overlays of Pax7/Fitc (top panel) and HNK1/Fitc (bottom panel). Scale bars: 200 mm (A–G),
100 mm (E0–G0).
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Fig. 4. Loss of Elk3 do not affect neural or ectodermal development. (A), (B) Whole mount in situ hybridization of Sox2 and (C), (D) immunohistochemistry showing no
change in expression for Sox2 and Pax6 in embryos electroporated with the E3MO alone ((A), (B), right side) or with the ContMO and E3MO ((C), (D), ContMO is on left side
and E3MO on right) at HH4. (E) Whole mount immunohistochemistry for Sox2 using an embryo electroporated with Elk3 at HH4 showing no effect. (C0–E0) Sections
showing that loss and gain of Elk3 does not lead to a loss of neural tissue marked by Sox2 (C0), (and E0) or dorsal neural tube and ectoderm marked by Pax6 (D0).
Scale bars: 200 mm (A–E), 100 mm (C0–E0).
C.D. Rogers et al. / Developmental Biology 374 (2013) 255–263 261Thus, they failed to recover from the early speciﬁcation and
migratory effects after loss of Elk3.Discussion
Elk3 is known to function as a transcriptional repressor that is
required for wound healing, tumor growth and angiogenesis in
mouse models, and also functions as an anti-oncogenic factor in
some cancers (Li et al., 2008; Nakade et al., 2004; Zheng et al.,
2003). Here we show that during development, Elk3 is expressed
in the cranial mesenchyme and the neural folds at the onset of
neural crest speciﬁcation, as well as in migratory crest cells at
later stages. Based on its conserved expression pattern in chick
(Fig. 1B), mouse (Ayadi et al., 2001a), and frog (Bowes et al.,
2010), together with high conservation in functional domains
(98%) across species (Fig. 1A), we speculate that Elk3 may play a
conserved role during vertebrate neural crest development.
Loss of function experiments demonstrate that Elk3 is critical
for normal neural crest development. The results show that Elk3
is required for the expression of the neural crest speciﬁer genes
FoxD3, Sox10 and Snail2 (Fig. 2), and that its knockdown leads to a
loss of migratory neural crest cells (Fig. 5) and later to abnormal
craniofacial development (Fig. S2). Interestingly, Elk3-morphant
cells in the dorsal neural tube maintain expression of Pax7
protein (Fig. 2G–J, Fig. 5F and G). These cells are unable to
upregulate FoxD3, Sox10 and Snail2 (Fig. 2A–F), or to migrate outof the neural tube (Figs. 3, 5), whereas neural development
proceeds normally (Fig. 4).
These results raise the intriguing possibility that cells receiving
the E3MO may be arrested in a progenitor or stem-cell like stage
prior to the expression of bona ﬁde neural crest markers, like
Sox10, Snail2 and FoxD3, suggesting that Elk3 may be a prerequi-
site for their subsequent expression. After Elk3 knock-down, the
cells are maintained in a Pax7þ but bona ﬁde neural crest marker
negative state, which we speculate represents a ‘‘progenitor’’
state. Although there is an apparent reduction in Elk3 transcript
levels around the time of neural tube closure, we cannot rule out
the possibility that even low levels of transcript, perhaps below
the level easily detectable by in situ hybridization, still produce
enough protein to have a critical effect on downstream genes. In
the context of the cranial neural crest gene regulatory network,
this places Elk3 in a critical position between neural plate border
and neural crest speciﬁer genes, functioning downstream of the
former, but upstream of the latter. Taken together, the results
reveal a novel developmental role for Elk3 in neural crest cell
speciﬁcation, outside of its known roles in angiogenesis and
cancer progression.
The neural plate border gene, Pax7, is required during gastru-
lation for NC cell fate speciﬁcation in chicken (Basch et al., 2006)
and later in development, Pax7-positive cells contribute to NC cell
derivatives (Murdoch et al., 2012). However, Pax7-null mice
exhibit very mild NC-related defects, but die soon after birth
(Mansouri et al., 1996). Mansouri et al. (1996) suggest that in the
mouse, Pax7 and its paralog, Pax3, may compensate for the loss of
Fig. 5. Knockdown of Elk3 severely effects cranial NC migration. ((A)–(D)) Whole mount in situ hybridization of Sox10 ((A), (B)) and Snail2 ((C), (D)) in embryos injected
with the E3MO at HH4 showing a dose-dependent response (1.5 mM and 3 mM as indicated on ﬁgure). ((E), (F)) Immunohistochemistry for HNK1 and Pax7 in HH9
embryos electroporated with ContMO on the left side and E3MO on the right side at HH4 (FITC in inset). (G) Section of an HH10 embryo immunostained for Pax7
(top panel) and overlayed with E3MO/FITC (bottom panel). Scale bars: 200 mm ((A)–(F)), 100 mm (G).
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Pax7 appears to be the dominant paralog since it is expressed
earlier than Pax3, and knockdown of Pax3 during gastrulation has
no effect on neural crest development (Basch et al., 2006).
The position of the E3MO containing cells in the dorsal neural
tube and their maintenance of Pax7 expression suggests that they
may represent either neural or neural crest progenitor cells. Given
that they have low levels of Sox2 expression (Fig. 4A–E), a known
marker for neural progenitor cells (Graham et al., 2003), we
speculate that they represent neural crest progenitors prior to
the expression of neural crest speciﬁer genes like FoxD3, Sox10
and Snail2. A similar situation has been observed for Pax7
expressing cells in the olfactory epithelium. Pax7 is expressed in
olfactory precursor cells, which are multipotent and can give rise
to multiple olfactory cell types (Murdoch et al., 2010). Our results
suggest that in the neural crest, Elk3 may be required for
the Pax7-positive dorsal neural tube cells to progress along the
NC program, such that they subsequently upregulate NC cell
speciﬁers enabling them to emigrate from the neural tube.Interestingly, we noted some cell death in the neural tube, which
does not express detectable Elk3 by in situ hybridization.
This neural cell death could be a non-cell autonomous effect
due to a role of Elk3 in the mesenchyme adjacent to the neural
tube (Fig. 1E0). Elk3 is also known to be a downstream effector of
FGF signaling, which is involved in neural development.
Our data show that loss of Elk3 at HH4 leads to a severe
reduction in migrating neural crest cells (Figs. 3, 5). One possible
explanation for the abrogation of NC cell migration observed in
Elk3-morphant embryos is that it may be a secondary conse-
quence of the block to NC cell speciﬁcation resulting in a failure to
exit the neural tube and initiate migration. Consistent with this
possibility, we observed numerous Pax7-positive cells retained in
the dorsal neural tube of morphant, but not control embryos, at
stages of active cranial NC migration (Fig. 5F and G). These
Pax7þ/Elk3-morphant cells apparently failed to migrate as the
numbers of Pax7þ cells were much reduced in the periphery.
Thus, we speculate that the lack of migration may be due to the
maintenance of progenitor status (Pax7-positive precursor cells)
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their failure to upregulate transcription factors like FoxD3 and
Sox10, which are required for NC cell speciﬁcation and migration
(Drerup et al., 2009; Stewart et al., 2006).
An alternative possibility is that Elk3 may be directly required
for the emigration of Pax7þ neural crest precursors cells. Elk3 is
expressed in migratory NC cells (Fig. 1E and E0) consistent with a
possible role in migration. However, Elk3 expression levels are
reduced in the dorsal neural tube just prior to EMT. It is possible
that Elk3 may regulate cell adhesion during NC cell migration in a
similar manner to its function in mouse embryonic ﬁbroblast
migration (Buchwalter et al., 2005), where it acts as a transcrip-
tional repressor. Thus, it would be interesting to test whether the
loss of Elk3 in the premigratory NC cell population leads to a
dysregulation of adhesion molecules, which are tightly regulated
during the process of EMT (Kerosuo and Bronner-Fraser, 2012).
The ﬁnding that Elk3 knockdown has a less severe, but still
apparent, effect on NC cell migration when injected just prior to
EMT (Fig. 3) seems consistent with a primary role in speciﬁcation
with an additional, but less penetrant role in migration.Conclusions
In summary, our study reveals a novel function for the tran-
scriptional regulator, Elk3, in neural crest development. The results
place Elk3 downstream of neural plate border genes and upstream
of neural crest speciﬁers in the NC gene regulatory network
(Betancur et al., 2010) and establish Elk3 as a protein required
for the progression of the NC program from progenitor to deﬁnitive
neural crest cell. This research has allowed us to elaborate the NC-
GRN and establish a new tier of regulation that may be critical for
maintenance of neural crest ‘‘stemness.’’Acknowledgements
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